| 1 |
33765714 | [The influence of XRCC1 gene polymorphism on the prognosis and safety of stage Ⅲ patients with colorectal cancer who received oxaliplatin based adjuvant chemotherapy]. | 2021 Mar 23 |
4 |
| 2 |
31325295 | Urinary and Genetic Biomonitoring of Polycyclic Aromatic Hydrocarbons in Egyptian Coke Oven Workers: Associations between Exposure, Effect, and Carcinogenic Risk Assessment. | 2019 Jul |
1 |
| 3 |
28676400 | Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells. | 2017 Aug 26 |
1 |
| 4 |
29153096 | Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients. | 2017 Dec |
1 |
| 5 |
25690281 | XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population. | 2015 May |
2 |
| 6 |
26770441 | Polymorphisms of ERCC1 and XRCC1 predict the overall survival of advanced gastric cancer patients receiving oxaliplatin-based chemotherapy. | 2015 |
3 |
| 7 |
24318863 | Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. | 2014 Mar |
1 |
| 8 |
24590266 | XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. | 2014 Jun |
3 |
| 9 |
23299794 | XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis. | 2013 Mar |
4 |
| 10 |
23327191 | Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer. | 2013 Jan |
3 |
| 11 |
23604281 | Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy. | 2013 Jun |
3 |
| 12 |
24328669 | Statement of retraction: Hongying Lv, Qicai Li, Wengsheng Qiu, Jinyu Xiang, Hongjun Wei, Hua Liang, Aihua Sui and Jun Liang "Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer". | 2013 Dec |
1 |
| 13 |
22549274 | Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer. | 2012 Oct |
5 |
| 14 |
22580644 | Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population. | 2012 Jun |
1 |
| 15 |
21418871 | [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy]. | 2011 Jan 25 |
1 |
| 16 |
21468552 | Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). | 2011 Mar-Apr |
1 |
| 17 |
21787270 | Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients. | 2011 Dec |
2 |
| 18 |
19960344 | The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. | 2010 Aug |
1 |
| 19 |
21029695 | [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. | 2010 Jul |
1 |
| 20 |
19247656 | Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. | 2009 Oct |
2 |
| 21 |
19414151 | Pharmacogenetics in chemotherapy of colorectal cancer. | 2009 |
1 |
| 22 |
17273745 | Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. | 2007 Mar |
1 |
| 23 |
17593927 | Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population. | 2007 Oct |
2 |
| 24 |
17009149 | Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? | 2006 Nov |
2 |
| 25 |
11712813 | A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. | 2001 Jul-Aug |
1 |